Products and Services

Direct from the cultivators to the patients

Our all organic, cannabis based medications have been sourced from leading cultivators in the United States, Canada and Uruguay. We are commencing with an introductory range of capsules, tinctures, vapes and sublingual oils and will expand in due course. All our products are manufactured to our high specifications and meet International GMP Standards. Because of our operational model, we can bring products into Australia that are up to 25% better priced than any locally produced products thus we can lower the cost of patient access by 100 of dollars each month.

Business Model

Summary – MOCA is focused on rapid expansion to meet the emerging market, thus we are bringing product into Australia, targeting New Zealand for exportation and then establishing cultivation facilities to grow organic marijuana.

Description - We commenced with being granted import and export licenses in Australia and have developed our own brand. The Australian market is still tightly regulated for patient access so we have targeted New Zealand who passed legislation for medical cannabis in December 2018. We are establishing a distribution facility in NZ to service a rapidly growing market. In the second phase, we will establish a cultivation facility in NZ. Our application to the NZ government was lodged in December 2018 and we await a positive response. Our cultivation facility will generate over $16 million of organic cannabis flowers per year.